Activation of Host TLR4 by Tenascin-C Correlates with MMP14-Driven Invasion in Gliomas
Overview
This study investigates the role of Tenascin-C (TNC) in glioblastoma invasion through Toll-like receptor 4 (TLR4) activation in myeloid cells. Findings indicate that TNC correlates with MMP14 expression.
Background
Glioblastoma (GBM) is the most aggressive primary brain tumor in adults, characterized by diffuse invasion and poor prognosis despite treatment. Understanding the mechanisms that drive GBM progression, particularly the role of the tumor microenvironment, is crucial for developing effective therapies. The interaction between tumor cells and non-malignant myeloid cells is particularly significant in facilitating tumor invasion.
Data Highlights
No numerical data or trial data presented in the source material.
Key Findings
Tenascin-C (TNC) is upregulated in glioblastoma and correlates with MMP14 expression.
TLR4 is enriched in CD11b+ tumor-associated myeloid cells and associated with immunoregulatory macrophage signatures.
High expression of both TNC and MMP14 is linked to shorter overall survival in glioma patients.
Activation of TLR4 by TNC in myeloid cells promotes MMP14 induction, contributing to glioma invasion.
Loss of TLR4 in host cells reduces glioma expansion and infiltrative behavior in organotypic brain slices.
Clinical Implications
Understanding the role of myeloid cells in glioma invasion could inform strategies to mitigate tumor progression.
Conclusion
The study highlights the role of TNC in glioblastoma invasion through TLR4 activation, linking extracellular matrix remodeling with innate immune responses in the tumor microenvironment.
